Menopausal hormone therapy: oncological risks
The review article presents an analysis of the literature over the past 10 years on the relationship of menopausal hormone therapy and the risks of developing malignant diseases in women, including risk factors, such as mutations in the BRCA1/2 genes. The main limiting factor in the appointment of m...
Main Authors: | Ekaterina V. Musina, Igor Yu. Kogan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2020-07-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/34976/pdf |
Similar Items
-
Menopausal hormone therapy and risk factors of breast cancer development
by: A E Protasova, et al.
Published: (2017-06-01) -
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy
by: Giulia Gava, et al.
Published: (2019-10-01) -
THE EFFECTS OF HORMONAL THERAPY IN MENOPAUSE
by: Eduard Crauciuc, et al.
Published: (2018-06-01) -
Menopausal hormone therapy in questions and answers – a manual for physicians of various specialties
by: Tomasz Paszkowski, et al.
Published: (2019-04-01) -
Menopausal hormone therapy: a course to improve the effectiveness
by: A L Unanyan, et al.
Published: (2017-10-01)